Mark A. Logomasini
Keine laufenden Positionen mehr
Profil
Mark A.
Logomasini served as President, Chief Executive Officer & Director at Bioject Medical Technologies, Inc. from 2012 to 2015.
Prior to that, he was Director of Business Development at Sigma-Aldrich Corp.
in 2010.
He also served as Chief Financial Officer & VP-Business Development at Molecular Medicine BioServices, Inc. Additionally, he was a Partner at Foothill Scientific Associates, Inc. from 2010 to 2011.
Logomasini received his undergraduate degree from Missouri University of Science & Technology and his MBA from Paul Merage School of Business.
Ehemalige bekannte Positionen von Mark A. Logomasini
| Unternehmen | Position | Ende |
|---|---|---|
| Foothill Scientific Associates, Inc. | Corporate Officer/Principal | 01.11.2011 |
| SIGMA-ALDRICH CORPORATION | Corporate Officer/Principal | 01.01.2010 |
Molecular Medicine BioServices, Inc.
 Molecular Medicine BioServices, Inc. Pharmaceuticals: MajorHealth Technology Molecular Medicine BioServices, Inc. is a company that provides services in the pharmaceutical industry. The company is based in Carlsbad, CA. The company has signed a manufacturing agreement with Cardium Therapeutics for the production of Generx and have expanded their services to better serve client vaccine development and testing needs. The company was acquired by Sigma-Aldrich Corp., part of Merck KGaA on November 19, 2015. | Finanzdirektor/CFO | - |
| BIOJECT MEDICAL TECHNOLOGIES INC. | Vorstandsvorsitzender | 24.02.2015 |
Ausbildung von Mark A. Logomasini
| Missouri University of Science & Technology | Undergraduate Degree |
| Paul Merage School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR. | Health Technology |
Sigma-Aldrich Corp.
 Sigma-Aldrich Corp. Wholesale DistributorsDistribution Services Sigma-Aldrich Corp. operates as a life science and technology material company. It develops, manufactures, purchases and distributes a broad range of biochemical and organic chemicals. Its services include basic research, product and process development, manufacturing and production, regulatory compliance, and facility operations. was founded in May 1975 and is headquartered in St. Louis, MO. | Distribution Services |
Molecular Medicine BioServices, Inc.
Molecular Medicine BioServices, Inc. Pharmaceuticals: MajorHealth Technology Molecular Medicine BioServices, Inc. is a company that provides services in the pharmaceutical industry. The company is based in Carlsbad, CA. The company has signed a manufacturing agreement with Cardium Therapeutics for the production of Generx and have expanded their services to better serve client vaccine development and testing needs. The company was acquired by Sigma-Aldrich Corp., part of Merck KGaA on November 19, 2015. | Health Technology |
| Foothill Scientific Associates, Inc. |
